Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Lipoxygenase (LOX) inhibitors block enzymes that insert molecular oxygen into arachidonic acid and related fatty acids. 5-Lipoxygenase (5-LOX) starts leukotriene synthesis, while 12-LOX and 15-LOX form hydroxylated lipid mediators linked to inflammation and ferroptosis. In 1990, leukotriene synthesis in intact cells was shown to require 5-lipoxygenase-activating protein (FLAP), a membrane partner of 5-LOX. The category covers both points of attack on the leukotriene pathway. Zileuton inhibits 5-LOX directly, whereas MK 886 suppresses leukotriene biosynthesis by binding FLAP. PD146176 is a 15-LOX inhibitor that also appears in ferroptosis research, where lipid peroxidation drives cell death. Baicalein, a flavone from Scutellaria baicalensis roots, is a plant-derived lipoxygenase inhibitor used across several of these models.
L-691831 is a potent ligand for the 5-lipoxygenase activating protein (FLAP). It is primarily utilized in binding assays to explore FLAP-related activities, particularly in leukocyte membranes. This compound enables the measurement of FLAP affinity for leukotriene synthesis inhibitors, providing insights into the mechanisms of leukotriene production and potential therapeutic targets in inflammatory conditions.
Out of stock
All 3 sizes
Synonyms: 9(R)-Hydroxyeicosatetraenoic acid
9(R)-HETE is an enantiomer of 9-HETE, comprising 50% of the racemic mixture (±)9-HETE. It functions as an activator of RXRγ-dependent transcription, demonstrating a 1.5-fold increase in activity at a concentration of 300 nM compared to controls. The stereochemical characterization of the (R) enantiomer is supported by chiral HPLC retention time comparisons with published data. This compound is valuable for studies investigating RXR signaling pathways and lipid metabolism.
